Healthcare & Life Sciences
Immitra Bio
Switzerland
1
Investors
About
Immitra Bio is a spin-off from ETH Zurich developing a platform for in vivo gene editing that enables off-the-shelf, single-injection gene therapies to correct genetic defects directly in the body to treat rare genetic disorders.
Explore Immitra Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.